STOCK TITAN

Vanguard (NYSE: CME) reports 36.25M shares, cites 01/12/2026 realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CME Group Inc: The Vanguard Group filed Amendment No. 9 to a Schedule 13G/A reporting 36,248,559 shares beneficially owned, representing 10.10% of common stock. The filing states shared voting power 3,697,661 and shared dispositive power 36,248,559. It notes an internal realignment effective 01/12/2026 that changed portfolio management and proxy voting roles within The Vanguard Group, Inc.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports a 10.10% stake with shared control; holdings remain substantial.

The filing lists 36,248,559 shares beneficially owned and 10.10% of the class, with shared voting power 3,697,661. This indicates significant economic exposure while voting influence is distributed among Vanguard entities.

Investor attention should focus on future amendments from Vanguard subsidiaries after the 01/12/2026 realignment; subsequent filings may disclose narrower, disaggregated ownership by those subsidiaries.

Amendment cites internal reorganization and reliance on SEC release for disaggregation.

The statement references SEC Release No. 34-39538 and says Vanguard anticipates reporting by subsidiaries on a disaggregated basis following the 01/12/2026 realignment. The filing is signed by the Head of Global Fund Administration on 03/05/2026.

Compliance observers should watch for further Schedule 13G/A or 13D filings from Vanguard affiliates that reflect redistributed voting or dispositive powers.






02/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/05/2026

FAQ

How many CME (CME) shares does The Vanguard Group report owning?

The Vanguard Group reports beneficial ownership of 36,248,559 shares. The filing states this equals 10.10% of CME's common stock and lists shared voting power of 3,697,661.

What voting and dispositive powers does Vanguard report for CME stock?

Vanguard reports 0 sole voting and dispositive power, 3,697,661 shared voting power, and 36,248,559 shared dispositive power. These figures are listed in Item 4 of the amendment.

When did Vanguard's internal realignment referenced in the filing occur?

The filing states the internal realignment became effective on 01/12/2026. It explains portfolio management and proxy voting roles changed within The Vanguard Group, Inc.

Will Vanguard subsidiaries report ownership separately after the realignment?

Yes. The filing states Vanguard anticipates certain subsidiaries or business divisions will report beneficial ownership separately. This is said to be in reliance on SEC Release No. 34-39538.

Who signed the Schedule 13G/A amendment for Vanguard and when?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature dated 03/05/2026. That signature appears at the end of the amendment.
CME Group

NASDAQ:CME

CME Rankings

CME Latest News

CME Latest SEC Filings

CME Stock Data

113.90B
355.02M
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States
CHICAGO